Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oncobiologics Inc (NASDAQ:ONS)

1.38
Delayed Data
As of 3:59pm ET
 +0.03 / +2.22%
Today’s Change
0.78
Today|||52-Week Range
4.37
-54.15%
Year-to-Date
No recent news for Oncobiologics Inc.

Today’s Trading

Previous close1.35
Today’s open1.37
Day’s range1.35 - 1.39
Volume19,227
Average volume (3 months)167,545
Market cap$33.7M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-44.73%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-42.91%
P/E ratioNM
Price/Sales24.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...-0.09-2.47%
BNTCBenitec Biopharma Lt...-0.07-2.76%
CBMXCombiMatrix Corp-0.05-0.63%
DRIODarioHealth Corp+0.11+5.31%
Data as of 3:59pm ET, 10/23/2017

Financials

Last reporting dateAugust 30, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$3.0M
Annual profit (last year)-$53.3M
Net profit margin-1,789.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Pankaj Mohan
CFO, Secretary &
Principal Accounting Officer
Lawrence A. Kenyon
Corporate headquarters
Cranbury, New Jersey

Forecasts